Evidence map›Paper›PMID 39284883›Full record

ArticleScientific reports2024

Regional and temporal genotype profiling of Clostridioides difficile in a multi-institutional study in Japan.

Yusaku Sagisaka, Miyako Ishibashi, Daisuke Hosokawa, Hikaru Nakagawa, Shinya Yonogi, Kenta Minami, Youichi Suzuki, Taku Ogawa, Akira Ukimura, Takashi Nakano and 2 more

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yusaku SagisakaDepartment of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
Miyako IshibashiDepartment of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
Daisuke HosokawaDepartment of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
Hikaru NakagawaDepartment of Clinical Laboratory, National Hospital Organization Nagoya Medical Center, 1-1, 4-Chome, Sannomaru, Naka-ku, Nagoya, Aichi, 460-0001, Japan.
Shinya YonogiDivision of Microbiology, Osaka Institute of Public Health, 1-3-69, Nakamichi, Higashinari-ku, Osaka, 537-0025, Japan.
Kenta MinamiInfection Control Center, Osaka Medical and Pharmaceutical University Hospital, 2-7 Daigaku-cho, Takatsuki City, Osaka, 569-8686, Japan.
Youichi SuzukiDepartment of Central Clinical Laboratory, Osaka Medical and Pharmaceutical University Hospital, 2-7 Daigaku-cho, Takatsuki City, Osaka, 569-8686, Japan.
Taku OgawaInfection Control Center, Osaka Medical and Pharmaceutical University Hospital, 2-7 Daigaku-cho, Takatsuki City, Osaka, 569-8686, Japan.
Akira UkimuraInfection Control Center, Osaka Medical and Pharmaceutical University Hospital, 2-7 Daigaku-cho, Takatsuki City, Osaka, 569-8686, Japan.
Takashi NakanoInfection Control Center, Osaka Medical and Pharmaceutical University Hospital, 2-7 Daigaku-cho, Takatsuki City, Osaka, 569-8686, Japan.
Jun KomanoDepartment of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan. jun.komano@ompu.ac.jp.ORCID 0000-0003-4610-1950
C. difficile Molecular Epidemiology Network of Japan

Funding

Japan Society for the Promotion of Science 18KK0270
6 · The paper itself

Abstract

Clostridioides difficile, a cause of healthcare-associated infections, poses a significant global health threat. This multi-institutional retrospective study focuses on epidemic dynamics, emphasizing minor and toxin-negative clinical isolates through high-resolution genotyping. The genotype of the C. difficile clinical isolates during 2005 to 2022 was gathered from 14 hospitals across Japan (N = 982). The total number of unique genotypes was 294. Some genotypes were identified in every hospital (cross-regional genotypes), while others were unique to a specific hospital or those in close geographic proximity (region-specific genotypes). Notably, a hospital located in a sparsely populated prefecture exhibited the highest prevalence of region-specific genotypes. The isolation rate of cross-regional genotypes positively correlated with the human mobility flow. A 6-month interval analysis at a university hospital from 2019 to 2021 revealed a temporal transition of the genotype dominance. The frequent isolation of identical genotypes over a brief timeframe did not always align with the current criteria for defining nosocomial outbreaks. This study highlights the presence of diverse indigenous C. difficile strains in regional environments. The cross-regional strains may have a higher competency to spread in the human community. The longitudinal analysis underscores the need for further investigation into potential nosocomial spread.

Indexed as

Clostridioides difficileClostridium InfectionsCross InfectionGenotypeFemaleHospitalsHumansJapanMaleRetrospective StudiesClostridioides difficileCross-regional genotypeInfectionMolecular epidemiologyRegion-specific genotype

Identifiers

PMID39284883
PMCPMC11405520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.